Le Lézard
Classified in: Health, Science and technology
Subjects: Conference Call, Webcast, Advisory

Gossamer Bio to Host Webcast Announcing its Next Clinical Product Candidates on October 11, 2021


Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced that it will host a conference call and webcast for investors and analysts on Monday, October 11, 2021, at 2:30 pm ET to announce its next clinical product candidates.

Gossamer management will present and discuss its forthcoming additions to its clinical product candidate pipeline. As part of the event, Gossamer Bio management will be available for questions.

Conference Call and Webcast

Gossamer will host a conference call and live audio webcast at 2:30 pm ET on Monday, October 11. The live audio webcast may be accessed through the "Events / Presentations" page in the "Investors" section of the Company's website at www.gossamerbio.com. Alternatively, the conference call may be accessed through the following:

Conference ID: 4165598
Domestic Dial-in Number: (833) 646-0603
International Dial-in Number: (929) 517-9782
Live Webcast: https://edge.media-server.com/mmc/p/4jha6kh9

A replay of the audio webcast will be available for 30 days on the "Investors" section of the Company's website, www.gossamerbio.com.

About Gossamer Bio

Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Its goal is to be an industry leader in each of these therapeutic areas and to enhance and extend the lives of patients suffering from such diseases.


These press releases may also interest you

at 09:38
Nonprofits from Inception Fertility and Caden Lane Team Up to Expand Financial Accessibility to Fertility Care
The Wyatt Foundation and The Conceive Fertility Foundation announce today a joint partnership that will award $15,000 grants to five individuals/couples who need in vitro fertility (IVF) to build their families. Launching during National Infertility...

at 09:38
Commons Clinic Invests $9.75M in Advanced Spine Surgery Center; Launches Next-Gen Ambulatory Surgical Platform "Theater"
New platform and surgery center investment adds advanced facility capabilities to specialty care network, strengthening in-person treatment and attracting leading orthopedic surgeons and physiciansWith Theater launch, value-based MSK care visionary...

at 09:35
Ryan Appoints New Chief Data Officer Chitranjan Sharma
Ryan, a leading global tax services and software provider, is pleased to announce that Chitranjan Sharma has been appointed as Chief Data Officer (CDO). Sharma brings more than a decade of extensive experience in building technology and data...

at 09:32
GLOW PRODUCTION BREAKS INTO NORTH AMERICA TO CONNECT AAA STUDIOS WITH GLOBAL AUDIENCES
GLOW Production, a leading cinematic development company in Malaysia, today announced it is opening its business to North American studios that have struggled to find sufficient international resources that can meet expedited pipelines and deliver...

at 09:26
CNFinance Files Annual Report on Form 20-F for Fiscal Year 2023
CNFinance Holdings Limited ("CNFinance" or the "Company"), a leading home equity loan service provider in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the U.S. Securities and...

at 09:15
JTV® Expands Product Line with Luxury Sunglasses and Watches
JTV®, the national jewelry retailer, broadcast network, and e-commerce platform, is excited to announce the highly anticipated addition of luxury sunglasses and watches to its portfolio of stunning jewelry, loose gemstones, and accessories. This...

More news about Science and technology...


News published on and distributed by: